PMC:7600245 / 3102-3534 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":173,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":328,"end":336},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":286,"end":289},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T9","span":{"begin":412,"end":415},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":69,"end":84},"obj":"Chemical"},{"id":"T8","span":{"begin":69,"end":78},"obj":"Chemical"},{"id":"T9","span":{"begin":79,"end":84},"obj":"Chemical"},{"id":"T10","span":{"begin":96,"end":119},"obj":"Chemical"},{"id":"T11","span":{"begin":114,"end":119},"obj":"Chemical"},{"id":"T12","span":{"begin":124,"end":137},"obj":"Chemical"},{"id":"T13","span":{"begin":138,"end":143},"obj":"Chemical"},{"id":"T14","span":{"begin":275,"end":285},"obj":"Chemical"},{"id":"T15","span":{"begin":400,"end":411},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_35472"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":173,"end":187},"obj":"Phenotype"},{"id":"T2","span":{"begin":196,"end":210},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":230,"end":386},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}

{"project":"LitCovid-PubTator","denotations":[{"id":"55","span":{"begin":196,"end":210},"obj":"Disease"},{"id":"65","span":{"begin":353,"end":361},"obj":"Species"},{"id":"67","span":{"begin":275,"end":285},"obj":"Chemical"},{"id":"68","span":{"begin":400,"end":411},"obj":"Chemical"},{"id":"71","span":{"begin":328,"end":336},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D001778"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Tax:9606"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:C000606551"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:C462182"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" unit (ICU) admission, and mechanical ventilation, appear to include antiviral drugs as well as anti-inflammatory drugs and anticoagulant drugs to also treat the associated cytokine storm [7] and coagulopathies [8], respectively.\nConsidering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. Furthermore, favipiravir has been approved fo"}